The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, China Isotope & Radiation's share price is HK$11.00.
China Isotope & Radiation's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$22.69. Hence, China Isotope & Radiation's PS Ratio for today is 0.48.
The historical rank and industry rank for China Isotope & Radiation's PS Ratio or its related term are showing as below:
HKSE:01763'
s PS Ratio Range Over the Past 10 Years
Min: 0.41 Med: 1.27 Max: 2.31
Current: 0.5
During the past 9 years, China Isotope & Radiation's highest PS Ratio was 2.31. The lowest was 0.41. And the median was 1.27.
HKSE:01763's PS Ratio is ranked better than 91.32% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 3.28
vs HKSE:01763: 0.50
During the past 9 years, China Isotope & Radiation's highest 3-Year average Revenue per Share Growth Rate was 18.80% per year. The lowest was 6.30% per year. And the median was 14.95% per year.
Back to Basics: PS Ratio
China Isotope & Radiation PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Isotope & Radiation's PS Ratio
For the Medical Devices subindustry, China Isotope & Radiation's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's PS Ratio distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's PS Ratio falls into.
China Isotope & Radiation PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
China Isotope & Radiation's Share Price of today is HK$11.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$22.69.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
China Isotope & Radiation (HKSE:01763) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
China Isotope & Radiation PS Ratio Related Terms
Thank you for viewing the detailed overview of China Isotope & Radiation's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
China Isotope & Radiation (HKSE:01763) Business Description
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01763 has been successfully added to your 